{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.89"},{"groupId":"OG001","value":"0.94"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"53"},{"groupId":"OG001","value":"47"}],"units":"Participants"}],"description":"Fever resolution between the two treatment groups was compared using Gray's model that takes into account death as a competing risk.","groups":[{"description":"Received antimicrobial therapy alone.","id":"OG000","title":"Control Arm"},{"description":"Received G-CSF/dexamethasone-mobilized granulocyte transfusions in addition to antimicrobial therapy.","id":"OG001","title":"Granulocyte Arm"}],"paramType":"NUMBER","populationDescription":"Subjects who had fever at baseline.","reportingStatus":"POSTED","timeFrame":"Measured through Day 42","title":"Fever Resolution","type":"SECONDARY","unitOfMeasure":"proportion of subjects, resolved fever"}